YEA CHRISTOPHER (Chief Development Officer) sold 1.0% of their position (2.36K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $63.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0001691102-26-000005
Officer· Chief Development Officer
Since Sep 2018
-2.36K
Net shares
Net seller
$63.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.75K acquired · 6.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.6%
5/21/2026
227.37K→231.12K
Common Stock
Direct
Shares
−2.36K
Price / share
$26.78
Trade value
$63.16K
% of position
1.0%
5/22/2026
231.12K→228.76K
Total
Net shares
+1.39K
Net value
-$63.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | M · Option Exercise | +3.75K | — | — | 1.6% | 227.37K | 231.12K |
| Common Stock Direct | 5/22/2026 | S · Sale | −2.36K | $26.78 | $63.16K | 1.0% | 231.12K | 228.76K |
| Total | +1.39K | -$63.16K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
41.25K
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 5/21/2026 | M · Option Exercise | −3.75K | — | 41.25K |